Highlights and Quick Summary
- Income Tax Provision for the quarter ending June 30, 2023 was $11.1 Million (a -49.32% decrease compared to previous quarter)
- Year-over-year quarterly Income Tax Provision decreased by -5.93%
- Annual Income Tax Provision for 2022 was $2.1 Million (a -97.49% decrease from previous year)
- Annual Income Tax Provision for 2021 was $83.5 Million (a -18.22% decrease from previous year)
- Annual Income Tax Provision for 2020 was $102 Million (a 345.85% increase from previous year)
- Twelve month Income Tax Provision ending June 30, 2023 was $61.6 Million (a 155.6% increase compared to previous quarter)
- Twelve month trailing Income Tax Provision decreased by -2.99% year-over-year
Trailing Income Tax Provision for the last four month:
30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
---|---|---|---|
$61.6 Million | $24.1 Million | $2.1 Million | $63.5 Million |
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income Tax Provision of Emergent Biosolutions Inc.
Most recent Income Tax Provisionof EBS including historical data for past 10 years.Interactive Chart of Income Tax Provision of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Income Tax Provision for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $11.1 | $21.9 | – | – | – |
2022 | $16.8 | $11.8 | $-26.4 | $-0.1 | $2.1 |
2021 | $78.2 | $-12.8 | $2.6 | $15.5 | $83.5 |
2020 | $67.4 | $15.5 | $28.0 | $-8.8 | $102.1 |
2019 | $24.6 | $15.7 | $-5.6 | $-11.8 | $22.9 |
2018 | $7.0 | $0.6 | $15.7 | $-4.5 | $18.8 |
2017 | $17.97 | $12.76 | $2.11 | $3.16 | $36.0 |
2016 | $16.84 | $13.17 | $-1.27 | $7.97 | $36.7 |
2015 | $27.01 | $20.06 | $5.5 | $-8.27 | $44.3 |
2014 | $27.8 | $7.87 | $2.47 | $-8.21 | $29.93 |
2013 | $8.44 | $4.8 | $4.38 | $-4.52 | $13.11 |
2012 | $9.28 | $4.24 | – | – | $13.92 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic